International Patent: RESPIRATORY SYNCYTIAL VIRUS ANTIGENIC POLYPEPTIDE, NUCLEIC ACID AND VACCINE, AND USE THEREOF

GENEVA, July 27 -- SHENZHEN RHEGEN BIOTECHNOLOGY CO.,LTD. filed a patent application (CN2026/072490) for “RESPIRATORY SYNCYTIAL VIRUS ANTIGENIC POLYPEPTIDE, NUCLEIC ACID AND VACCINE, AND USE THEREOF”. With publication no. WO/2026/153357, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 14/135

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....